Syndesmosis and Syndesmotic Equivalent Injuries in Tibial Plafond Fractures.


Journal

Journal of orthopaedic trauma
ISSN: 1531-2291
Titre abrégé: J Orthop Trauma
Pays: United States
ID NLM: 8807705

Informations de publication

Date de publication:
Mar 2019
Historique:
entrez: 16 2 2019
pubmed: 16 2 2019
medline: 26 5 2020
Statut: ppublish

Résumé

To identify the incidence and fracture characteristics associated with syndesmotic injury in tibial plafond fractures and report the incidence of posttraumatic osteoarthrosis (PTOA). Retrospective comparative study. Two level-1 academic trauma centers. Of the 735 tibial plafond fractures (OTA/AO 43-B3 and 43-C) treated from January 2006 through December 2015, 108 patients (108/735, 15%) were identified with syndesmosis injury. Either acute or missed syndesmotic injury. PTOA. Fourteen fractures (14/735, 2%) had missed syndesmotic injury. Volkmann fragment of ≤10 mm (P = 0.04) and fibular avulsion fracture (P = 0.05) were significantly more common in missed syndesmosis. Ninety fractures (14/14 missed, 76/94 acute) had greater than 12-month follow-up (mean, 26 months; range, 12-102 months). Nearly all patients with missed syndesmosis injury developed arthrosis (13/14, 93%), and 45% (34/76 fractures) of plafond fractures with acute syndesmosis injury developed arthrosis (P < 0.001). Although controlling for malreduction, patients with missed syndesmosis had significantly more PTOA development (P = 0.018). Controlling for malreduction, patients with syndesmotic fixation and a ≤10-mm Chaput or Volkmann fragment or fibular avulsion fracture (8/31, 26%) were less likely to develop PTOA than if they had a similar fracture pattern without syndesmotic fixation (9/10, 90%) (P = 0.011). Fifteen percent of tibia plafond fractures have a syndesmosis or syndesmotic equivalent injury. Missed syndesmosis injury has a high rate of PTOA development. Patients with a ≤10-mm Chaput or Volkmann fragment and/or fibular avulsion fracture benefit from syndesmotic fixation. Prognostic Level IV. See Instructions for Authors for a complete description of levels of evidence.

Identifiants

pubmed: 30768532
doi: 10.1097/BOT.0000000000001363
pii: 00005131-201903000-00010
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e74-e78

Auteurs

Justin M Haller (JM)

Department of Orthopaedic Surgery, University of Utah School of Medicine, Salt Lake City, UT.

Michael Githens (M)

Department of Orthopedic Surgery, Harborview Medical Center, University of Washington, Seattle, WA.

David Rothberg (D)

Department of Orthopaedic Surgery, University of Utah School of Medicine, Salt Lake City, UT.

Thomas Higgins (T)

Department of Orthopaedic Surgery, University of Utah School of Medicine, Salt Lake City, UT.

David Barei (D)

Department of Orthopedic Surgery, Harborview Medical Center, University of Washington, Seattle, WA.

Sean Nork (S)

Department of Orthopedic Surgery, Harborview Medical Center, University of Washington, Seattle, WA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH